The present study aimed to examine the KRAS expression in oral epithelial dysplasia and squamous cell carcinoma of the oral cavity and to correlate its expression with the established prognostic markers (Ki-67, bcl2, and Cyclin D1) and the available clinicopathologic factors. This evidence concerns the gene KRAS and dysplastic oral keratinocyte.